Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12

British Journal of Haematology

Volumn 100, Issue 3, 1998, Pages 521-533

  Streubel, Berthold ^a   Sauerland, Cristina ^b   Heil, Gerhard ^c   Freund, Mathias ^d   Bartels, Heinrich ^e   Lengfelder, Eva ^f   Wandt, Hannes ^g   Ludwig, Wolf Dieter ^h   Nowotny, Hadwiga ⁱ   Baldus, Michael ^j   Grothaus Pinke, Bernward ^k   Büchner, Thomas ^k   Fonatsch, Christa ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Inst F Med Informatik B   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g KLINIKUM NÜRNBERG   (Germany)

^h Section of Pathology   (Germany)

ⁱ HANUSCH HOSPITAL   (Austria)

^j KLINIKUM LUDWIGSHAFEN   (Germany)

^k UNIVERSITY OF MÜNSTER   (Germany)

more..

Author keywords

12p abnormalities; ANLL; ETV6; FISH; MDS

Indexed keywords

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME 12P; CHROMOSOME ARM; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DUPLICATION; GENOTOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MUTAGENICITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 15644381022     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00591.x     Document Type: Article

References (33)

1. Andreasson, P., Johansson, B., Arheden, K., Billstrom, R., Mitelman, F. & Hoglund, M. (1997) Deletions of CDKN1b and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes, Chromosomes and Cancer, 19, 77-83.
2. Berger, R., Bernheim, A., Le Coniat, M., Vecchione, D., Pacot, A., Daniel, M.T. & Flandrin, G. (1986) Abnormalities of the short arm of chromosome 12 in acute nonlymphocytic leukemia and dysmyelopoietic syndrome. Cancer Genetics and Cytogenetics, 19, 281-289.
3. Berger, R., Leconiat, M., Lacronique, V. Daniel, M.T., Lessard, M., Berthou, C., Marynen, P. & Bernard, O. (1997) Chromosome abnormalities of the short arm of chromosome 12 in hematopoietic malignancies: a report including three novel translocations involving the TEL/ETV6 gene. Leukemia, 11, 1400-1403.
4. Bohlander, S.K., Espinosa, R., III, Fernald, A.A., Rowley, J.D., Le Beau, M.M. & Diaz, M.O. (1994) Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenetics and Cell Genetics, 65, 108-110.
5. Buijs, A., Sherr, S., van Baal, S., van Bezouw, S., van der Plas, D., Geurts van Kessel, A., Riegman, P. Lekanne Deprez, R., Zwarthoff, E., Hagemeijer, A. & Grosveld, G. (1995) Translocation (12:22)(p13:q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene, 10, 1511-1519.
6. Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Gray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D. & Gilliland, D.G. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 92, 4917-4921.
7. Golub, T.R., Barker, G.F., Lovett, M. & Gilliland, D.G. (1994) Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5:12) chromosomal translocation. Cell, 77, 307-316.
8. Harada, H., Harada, Y., Eguchi, M., Dohy, H. & Kamada, N. (1997) Characterization of acute leukemia with t(4:12). Leukemia and Lymphoma, 25, 47-53.
9. Höglund, M., Johansson, B., Pedersen-Bjergaard, J., Marynen, P. & Mitelman, F. (1996) Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood, 87, 324-330.
10. ISCN (1995) Guidelines for cancer cytogenetics. In: Supplement to an International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman), Karger, Basel.
11. Kobayashi, H., Montgomery, K.T., Bohlander, S.K., Chaker, N.A., Lim, B.L., Kucherlapati, R.S., Donis-Keller, H., Holt, M.S., Le Beau, M.M. & Rowley, J.D. (1994) Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood, 84, 3473-3482.
12. Kuefer, M., Look, A.T., Williams, D.C., Valentine, V., Naeve, C.W., Behm, F.G., Mullersman, J.E., Yoneda-Kato, N., Montgomery, K., Kucherlapati, R., Morris, S.W. (1996) cDNA cloning, tissue distribution, and chromosomal localization of myelodysplasia/ myeloid leukemia factor 2 (MLF2). Genomics, 35, 392-396.
13. Mitelman, F. (1994) Catalog of Chromosome Aberrations in Cancer, 5th edn. Wiley-Liss, New York.
14. Papadopoulos, P., Ridge, S.A., Boucher, C.A., Stocking, C. & Wiedemann, L.M. (1995) The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Research, 55, 34-38.
15. Pedersen-Bjergaard, J. & Philip, P. (1987) Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases. British Journal of Haematology, 66, 199-207.
16. Peeters, P., Raynaud, S.D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Vanrompaey, L., Baens, M., Vandenberghe, H. & Marynen, P. (1997a) Fusion of TEL, the ETS variant gene 6 (ETV6), to the receptor associated kinase JAK2 as a result of t(9:12) in a lymphoid and t(9:15:12) in a myeloid leukemia. Blood, 90, 2535-2540.
17. Peeters, P., Wlodarska, I., Baens, M., Criel, A., Selleslag, D., Hagemeijer, A., Vandenberghe, H. & Marynen, P. (1997b) Fusion of ETV6 to MDS1/EVI1 as a result of t(3:12)(q26:p13) in myeloproliferative disorders. Cancer Research, 57, 564-569.
18. Raimondi, S.C. (1993) Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood, 81, 2237-2251.
19. Raimondi, S.C., Williams, D.L., Callihan, T., Peiper, S., Rivera, G.K. & Murphy, S.B. (1986) Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood, 68, 69-75.
20. Raynaud, S.D., Baens, M., Grosgeorge, J., Rodgers, K., Reid, C.D.L., Dainton, M., Dyer, M., Fuzibet, J.G., Gratecos, N., Taillan, B., Ayraud, N. & Marynen, P. (1996) Fluorescence in situ hybridization analysis of t(3:12)(q26:p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood, 88, 682-689.
21. Rieder, H., Kolbus, U., Koop, U., Ludwig, W.D., Stollmann-Gibbels, B. & Fonatsch, C. (1993) Translocation t(1:22) mimicking t(1:19) in a child with acute lymphoblastic leukemia as revealed by chromosome painting. Leukemia, 7, 1663-1666.
22. Romana, S.P., Poirel, H., Leconiat, M., Flexor, M.A., Mauchauffe, M., Jonveaux, P., Macintyre, E.A., Berger, R. & Bernard, O.A. (1995) High frequency of t(12:21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263-4269.
23. Sato, Y., Suto, Y., Pietenpol, J., Golub, T.R., Gilliland, D.G., Davis, E.M., Le Beau, M.M., Roberts, J.M., Vogelstein, B., Rowley, J.D. & Bohlander, S.K. (1995) TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood, 86, 1525-1533.
24. Schnittger, S., Schoch, C., Streubel, B., Hinrichs, H.F. Otremba, B., Parwaresch, R. & Fonatsch, C. (1997) A case of atypical myelodsplastic syndrome with micromegakaryocytes, normal platelet count, and t(3:12)(q21:p13) with inv(3)(q21q26). Genes, Chromosomes and Cancer, 20, 292-298.
25. Shurtleff, S.A., Buijs, A., Behm, F.G., Rubnitz, J.E., Raimondi, S.C., Hancock, M.L., Chan, G.C., Pui, C.H., Grosveld, G. & Downing, J.R. (1995) TEL/AML1 fusion resulting from a cryptic t(12:21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 95, 1985-1989.
26. Stollmann, B., Fonatsch, C. & Havers, W. (1985) Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders. British Journal of Haematology, 60, 183-196.
27. Suto, Y., Sato, Y., Smith, S.D., Rowley, J.D. & Bohlander, S.K. (1997) A t(6:12)(q23:p13) results in the fusion of ETV6 to a novel gene. STL, in a B-cell ALL cell line. Genes, Chromosomes and Cancer, 18, 254-268.
28. Tosi, S., Mosna, G., Cazzaniga, G., Giudici, G., Kearney, L., Biondi, A. & Privitera, E. (1997) Unbalanced t(13:12) in a case of juvenile myelomonocytic leukemia (JMML) results in partial trisomy of 3q as defined by FISH. Leukemia, 11, 1465-1468.
29. Tosi, S., Stilgenbauer, S., Giudici, G., Capalbo, S., Specchia, G., Liso, V., Castagna, S., Lanzi, E., Lichter, P. & Biondi, A. (1994) Reciprocal translocation t(12:13)(p13:q14) in acute nonlymphoblastic leukemia: report and cytogenetic analysis of two cases. Cancer Genetics and Cytogenetics, 77, 106-110.
30. UKCCG (1992) Translocations involving 12p in acute myeloid leukemia: association with prior myelodysplasia and exposure to mutagenic agents. Genes, Chromosomes and Cancer, 5, 252-254.
31. Weh, H.J. & Hossfeld, D.K., (1986) 12p-chromosome in patients with acute myelocytic leukemia or myelodysplastic syndromes following exposure to mutagenic agents. Cancer Genetics and Cytogenetics, 19, 355-356.
32. Wilmoth, D., Feder, M., Finan, J. & Nowell, P. (1985) Preleukemia and leukemia with 12p- and 19q+ chromosome alterations following alkeran therapy. Cancer Genetics and Cytogenetics, 15, 95-98.
33. Wlodarska, I., Mecucci, C., Marynen, P., Guo, C., Franckx, D., La Straza, R., Aventin, A., Bosly, A., Martelli, M.F., Cassiman, J.J. & van den Berghe, H. (1995) Tel gene is involved in myelodysplastic syndromes with either the typical t(5:12)(q33:p13) translocation or its variant t(10:12)(q24:p13). Blood, 85, 2848-2852.